全文获取类型
收费全文 | 20561篇 |
免费 | 2446篇 |
国内免费 | 422篇 |
专业分类
耳鼻咽喉 | 432篇 |
儿科学 | 948篇 |
妇产科学 | 1111篇 |
基础医学 | 2041篇 |
口腔科学 | 344篇 |
临床医学 | 2302篇 |
内科学 | 2863篇 |
皮肤病学 | 178篇 |
神经病学 | 1017篇 |
特种医学 | 599篇 |
外国民族医学 | 4篇 |
外科学 | 1474篇 |
综合类 | 1642篇 |
现状与发展 | 2篇 |
预防医学 | 2827篇 |
眼科学 | 536篇 |
药学 | 1965篇 |
32篇 | |
中国医学 | 409篇 |
肿瘤学 | 2703篇 |
出版年
2024年 | 54篇 |
2023年 | 516篇 |
2022年 | 624篇 |
2021年 | 1131篇 |
2020年 | 1106篇 |
2019年 | 1046篇 |
2018年 | 954篇 |
2017年 | 955篇 |
2016年 | 984篇 |
2015年 | 950篇 |
2014年 | 1468篇 |
2013年 | 2045篇 |
2012年 | 1193篇 |
2011年 | 1250篇 |
2010年 | 1009篇 |
2009年 | 945篇 |
2008年 | 963篇 |
2007年 | 890篇 |
2006年 | 753篇 |
2005年 | 647篇 |
2004年 | 557篇 |
2003年 | 540篇 |
2002年 | 378篇 |
2001年 | 345篇 |
2000年 | 250篇 |
1999年 | 248篇 |
1998年 | 212篇 |
1997年 | 192篇 |
1996年 | 142篇 |
1995年 | 134篇 |
1994年 | 121篇 |
1993年 | 101篇 |
1992年 | 111篇 |
1991年 | 76篇 |
1990年 | 81篇 |
1989年 | 54篇 |
1988年 | 57篇 |
1987年 | 51篇 |
1986年 | 41篇 |
1985年 | 55篇 |
1984年 | 37篇 |
1983年 | 30篇 |
1982年 | 30篇 |
1981年 | 27篇 |
1980年 | 16篇 |
1979年 | 13篇 |
1978年 | 11篇 |
1977年 | 8篇 |
1976年 | 9篇 |
1973年 | 7篇 |
排序方式: 共有10000条查询结果,搜索用时 515 毫秒
101.
目的 探讨血液肿瘤患者肛拭子耐碳青霉烯类肠杆菌(CRE)主动筛查情况及继发血流感染的影响因素。方法 选取2020年9月—2022年6月在苏州大学附属第一医院治疗的血液肿瘤患者1 258例,所有患者行肛拭子CRE主动筛查,分析CRE定植分布、血流感染情况及其影响因素。结果 共检出CRE 109株,以肺炎克雷伯菌、大肠埃希菌为主;10例患者发生CRE血流感染;CRE酶型分布中,主要以NDM、KPC为主;有中性粒细胞缺乏患者CRE定植发生率高于无中性粒细胞缺乏患者(P<0.05);有消化道症状患者CRE定植发生率高于无消化道症状患者(P<0.05);多因素逐步Logistic回归分析结果显示,中性粒细胞缺乏■是血液肿瘤患者CRE定植发生的影响因素(P<0.05)。不同性别、年龄、疾病类型及有无中性粒细胞缺乏、消化道症状患者的血流感染发生率比较,差异均无统计学意义(P>0.05)。结论 血液肿瘤患者肛拭子CRE主动筛查能有效筛出CRE感染者,CRE定植感染与中性粒细胞缺乏有关,临床应加以重视。 相似文献
102.
Jan Frisell Gunnar Eklund Lars Hellström Ulla Glas Anders Somell 《Breast cancer research and treatment》1989,13(1):79-87
In screening programmes it is important to assess a preliminary effectiveness of the screening method as soon as possible in order to forecast survival figures. In March 1981 a controlled single-view mammographic screening trial for breast cancer was started in the south of Stockholm. The population invited for screening mammography consisted of 40,000 women aged 40–64 years, and 20,000 women served as a well-defined control group. The main aim of the trial was to determine whether repeated mammographic screening could reduce the mortality in the study population (SP) compared to the control population (CP).The cumulative number of advanced mammary carcinomas in the screening and the control populations from the first five years of screening have shown a tendency towards more favourable stages in the screened population aged 40–64 years. A breakdown by age suggests an effect in age group 50–59 years, but not yet in age groups 40–49 and 60–64 years.When comparing the rates of stage II+ cancer, an increased number is found in the study group. As the total rate of breast cancer is higher in SP than in CP, there ought to be a concealed group of stage II+ cancers in the CP which makes the comparison biased. A new approach has been designed, where an estimation of the hidden number of stage II+ cancers in CP is added to the clinically detected cases, and in this respect a comparison has shown a decrease in the cumulative number of advanced cancers in the SP in relation to the CP (p<0.05). According to this it could be important to add the estimated number of undetected, hidden cases in the control group in order to utilize the difference in detection rate in the screening- and control group respectively. 相似文献
103.
Denaturing high performance liquid chromatography (DHPLC) using ion-pairing reverse phase chromatography (IPRPC) columns is a technique for the screening of gene mutations. In order to evaluate the potential utility of this assay method in a clinical laboratory setting, we subjected the PCR products of 73 CF patients known to bear CFTR mutations to this analytic technique. We used thermal denaturation profile parameters specified by the MELT program tool, made available by Stanford University. Using this strategy, we determined an initial analytic sensitivity of 90.4% for any of 73 known CFTR mutations. Most of the mutations not detected by DHPLC under these conditions are alpha-substitutions. This information may eventually help to improve the MELT algorithm. Increasing column denaturation temperatures for one or two degrees above those recommended by the MELT program allowed 100% detection of CFTR mutations tested. By comparing DHPLC methodology used in this study with the recently reported study based on Wavemaker 3.4.4 software (Transgenomic, Omaha, NE) [Le Marechal et al., 2001) and with previous SSCP analysis of CFTR mutations [Ravnik-Glavac et al., 1994] we emphasized differences and similarities in order to refine the DHPLC system and discuss the relationship to the alternative approaches. We conclude that the DHPLC method, under optimized conditions, is highly accurate, rapid, and efficient in detecting mutations in the CFTR gene and may find high utility in screening individuals for CFTR mutations. Hum Mutat 19:374-383, 2002. Published 2002 Wiley-Liss, Inc. 相似文献
104.
Xiang F Buervenich S Nicolao P Bailey ME Zhang Z Anvret M 《Journal of medical genetics》2000,37(4):250-255
Rett syndrome (RTT) was first described in 1966. Its biological and genetic foundations were not clear until recently when Amir et al reported that mutations in the MECP2 gene were detected in around 50% of RTT patients. In this study, we have screened the MECP2 gene for mutations in our RTT material, including nine familial cases (19 Rett girls) and 59 sporadic cases. A total of 27 sporadic RTT patients were found to have mutations in the MECP2 gene, but no mutations were identified in our RTT families. In order to address the possibility of further X chromosomal or autosomal genetic factors in RTT, we evaluated six candidate genes for RTT selected on clinical, pathological, and genetic grounds: UBE1 (human ubiquitin activating enzyme E1, located in chromosome Xp11.23), UBE2I (ubiquitin conjugating enzyme E2I, homologous to yeast UBC9, chromosome 16p13.3), GdX (ubiquitin-like protein, chromosome Xq28), SOX3 (SRY related HMG box gene 3, chromosome Xq26-q27), GABRA3 (gamma-aminobutyric acid type A receptor alpha3 subunit, chromosome Xq28), and CDR2 (cerebellar degeneration related autoantigen 2, chromosome 16p12-p13.1). No mutations were detected in the coding regions of these six genes in 10 affected subjects and, therefore, alterations in the amino acid sequences of the encoded proteins can be excluded as having a causative role in RTT. Furthermore, gene expression of MECP2, GdX, GABRA3, and L1CAM (L1 cell adhesion molecule) was also investigated by in situ hybridisation. No gross differences were observed in neurones of several brain regions between normal controls and Rett patients. 相似文献
105.
M De Paschale C Agrappi P Clerici P Mirri M T Manco S Cavallari E F Viganò 《Clinical microbiology and infection》2008,14(2):186-189
The decreasing prevalence of anti-Toxoplasma antibodies in Europe has re-opened the question of the appropriateness of serological screening during pregnancy. A study of 3426 pregnant women, resident in the Legnano area of Italy, revealed that the IgG seroprevalence according to ELISA was 21.5%, and that of IgM according to ELISA and enzyme-linked fluorescent assay was 1.2% and 0.9%, respectively. The incidence of infection, estimated on the basis of IgG avidity, was 0.9%. These results confirm a decrease in the prevalence of IgG, but indicate a high incidence of infection, thus suggesting that screening for anti-Toxoplasma antibodies during pregnancy should be maintained. 相似文献
106.
Immunoprecipitation of radiolabeled polypeptides from complex mixtures of proteins was performed in polystyrene microtiter plates using staphylococcus protein A and various antibody preparations. The method is (1) rapid, (2) uses multichannel micropipettor technology, (3) handles large numbers of specimen easily, (4) requires very small volumes of antigen and antibody (5–50 μl), (5) provides replicates for statistical analysis and (6) allows recovery of precipitated proteins for direct SDS-PAGE analysis of precipitated proteins. We have shown it is useful as a test to screen large numbers of sera or to characterize monoclonal antibody-containing samples. 相似文献
107.
介绍了用于常规乳腺检测的X线摄影、超声成像和红外成像等各种影像学技术,通过分析这些技术的病理学以及影像学特征,找到它们在普查学中的意义。此外,还介绍了一种新兴的技术——热断层成像。 相似文献
108.
An automated multiphasic-health-test system has been opened in Japan for the early detection and treatment of disease in adults. The centre utilises system simulation, digital computation and automated medical equipment, and has made it possible to handle many examinees daily, and to retrieve their data easily. This paper reports many new data and their analysis. 相似文献
109.
A computer model was designed as a relational database to assess breast cancer screening in a cohort of women where the growth and development of breast cancer originates with the first malignant cell. The concepts of thresholds for growth, axillary spread, and distant sites are integrated. With tumor diagnosis, staging was performed that includes clinical and sub-clinical states. The model was parameterized to have staging characteristics similar to data published by the Surveillance, Epidemiology, and End-Results (SEER) Program. Validation was accomplished by comparing simulated staging results with non-SEER sources, and simulated survival with independent clinical survival data. 相似文献
110.
Mutations in the human fibrillin 1 gene (FBN1) cause the Marfan syndrome (MFS), an autosomal dominant connective tissue disorder. Knowledge about FBN1 mutations is important for early diagnosis, management, and genetic counseling. However, mutation detection in FBN1 is a challenge because the gene is very large in size ( approximately 200 kb) and the approximately 350 mutations detected so far are scattered over 65 exons. Conventional methods for large-scale detection of mutations are expensive, technically demanding, or time consuming. Recently, a high-capacity low-cost mutation detection method was introduced based on denaturing high-performance liquid chromatography (DHPLC). To assess the sensitivity and specificity of this method, we blindly screened 64 DNA samples of known FBN1 genotype exon-by-exon using exon-specific DHPLC conditions. Analysis of 682 PCR amplicons correctly identified 62 out of 64 known sequence variants. In three MFS patients of unknown FBN1 genotype, we detected two mutations and eight polymorphisms. Overall, 20 mutations and two polymorphisms are described here for the first time. Our results demonstrate 1) that DHPLC is a highly sensitive (89-99%, P = 0.05) method for FBN1 mutation detection; but 2) that chromatograms with moderate and weak pattern abnormalities also show false positive signals (in all 45-59%, P = 0.05); 3) that the difference in the chromatograms of heterozygous and homozygous amplicons is mostly independent of the type of sequence change; and 4) that DHPLC column conditions, additional base changes, and the amounts of injected PCR products influence significantly the shape of chromatograms. A strategy for FBN1 mutation screening is discussed. 相似文献